Kathryn Horwitz
Concepts (513)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Progesterone | 108 | 2020 | 326 | 11.260 |
Why?
| Breast Neoplasms | 116 | 2021 | 1994 | 6.940 |
Why?
| Progesterone | 46 | 2021 | 243 | 5.620 |
Why?
| Receptors, Estrogen | 55 | 2014 | 388 | 4.310 |
Why?
| Progestins | 23 | 2021 | 78 | 3.030 |
Why?
| Estrogens | 17 | 2014 | 325 | 2.190 |
Why?
| Gene Expression Regulation, Neoplastic | 21 | 2015 | 1183 | 2.090 |
Why?
| Tamoxifen | 26 | 2012 | 198 | 1.880 |
Why?
| Transcription, Genetic | 29 | 2012 | 1355 | 1.820 |
Why?
| Estradiol | 28 | 2014 | 477 | 1.800 |
Why?
| SUMO-1 Protein | 4 | 2012 | 21 | 1.060 |
Why?
| Tumor Cells, Cultured | 31 | 2009 | 904 | 0.840 |
Why?
| Gene Expression Profiling | 13 | 2014 | 1625 | 0.820 |
Why?
| Keratin-5 | 4 | 2014 | 47 | 0.810 |
Why?
| Neoplasms, Hormone-Dependent | 8 | 2010 | 38 | 0.770 |
Why?
| Promegestone | 24 | 2005 | 33 | 0.740 |
Why?
| Transcription Factors | 12 | 2009 | 1616 | 0.700 |
Why?
| Biomarkers, Tumor | 8 | 2020 | 1076 | 0.690 |
Why?
| Stromal Cells | 5 | 2014 | 103 | 0.680 |
Why?
| Gene Expression Regulation | 10 | 2011 | 2491 | 0.670 |
Why?
| Cell Proliferation | 9 | 2014 | 2328 | 0.660 |
Why?
| Protein Processing, Post-Translational | 4 | 2013 | 421 | 0.630 |
Why?
| Female | 102 | 2021 | 63629 | 0.630 |
Why?
| HeLa Cells | 15 | 2012 | 609 | 0.620 |
Why?
| Estrogen Replacement Therapy | 2 | 2008 | 118 | 0.620 |
Why?
| Promoter Regions, Genetic | 12 | 2012 | 1188 | 0.610 |
Why?
| Humans | 153 | 2021 | 122796 | 0.600 |
Why?
| Cell Line, Tumor | 19 | 2014 | 2904 | 0.600 |
Why?
| Medroxyprogesterone Acetate | 3 | 2005 | 30 | 0.560 |
Why?
| Neoplastic Stem Cells | 3 | 2008 | 340 | 0.530 |
Why?
| Antineoplastic Agents, Hormonal | 6 | 2010 | 143 | 0.530 |
Why?
| Cell Nucleus | 26 | 2008 | 598 | 0.530 |
Why?
| Mifepristone | 11 | 2000 | 66 | 0.520 |
Why?
| Neovascularization, Pathologic | 2 | 2014 | 292 | 0.520 |
Why?
| Lymphatic Metastasis | 4 | 2010 | 310 | 0.520 |
Why?
| Animals | 51 | 2014 | 34133 | 0.510 |
Why?
| Mice | 26 | 2014 | 15888 | 0.510 |
Why?
| Platelet-Derived Growth Factor | 2 | 2014 | 85 | 0.510 |
Why?
| Histone Acetyltransferases | 4 | 2012 | 53 | 0.500 |
Why?
| Epigenomics | 1 | 2015 | 108 | 0.490 |
Why?
| Phosphorylation | 18 | 2013 | 1733 | 0.490 |
Why?
| Down-Regulation | 8 | 2009 | 654 | 0.490 |
Why?
| Molecular Sequence Data | 21 | 2009 | 2933 | 0.490 |
Why?
| Epidermal Growth Factor | 8 | 2005 | 173 | 0.480 |
Why?
| Transcriptional Activation | 8 | 2009 | 360 | 0.470 |
Why?
| Epithelium | 3 | 2013 | 309 | 0.460 |
Why?
| Mice, Nude | 9 | 2012 | 668 | 0.450 |
Why?
| Protein Isoforms | 6 | 2011 | 347 | 0.430 |
Why?
| Cell Division | 12 | 2003 | 788 | 0.420 |
Why?
| MCF-7 Cells | 4 | 2020 | 115 | 0.420 |
Why?
| Cell Line | 34 | 2009 | 2785 | 0.420 |
Why?
| Binding Sites | 15 | 2006 | 1247 | 0.410 |
Why?
| DNA-Binding Proteins | 10 | 2000 | 1384 | 0.410 |
Why?
| Repressor Proteins | 5 | 2002 | 384 | 0.400 |
Why?
| Enzyme Inhibitors | 3 | 2008 | 836 | 0.400 |
Why?
| Cyclins | 4 | 1999 | 82 | 0.390 |
Why?
| Models, Biological | 5 | 2014 | 1756 | 0.390 |
Why?
| Receptors, Notch | 1 | 2011 | 88 | 0.390 |
Why?
| Neoplasm Proteins | 4 | 2005 | 415 | 0.390 |
Why?
| DNA | 11 | 2000 | 1401 | 0.380 |
Why?
| Epigenesis, Genetic | 1 | 2015 | 551 | 0.380 |
Why?
| Signal Transduction | 17 | 2012 | 4902 | 0.380 |
Why?
| DNA Methylation | 1 | 2015 | 511 | 0.380 |
Why?
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2010 | 8 | 0.380 |
Why?
| Peritoneal Neoplasms | 1 | 2010 | 56 | 0.370 |
Why?
| Adenocarcinoma | 2 | 2014 | 837 | 0.360 |
Why?
| Nuclear Proteins | 7 | 2000 | 618 | 0.360 |
Why?
| Transplantation, Heterologous | 6 | 2009 | 194 | 0.360 |
Why?
| Alu Elements | 1 | 2009 | 21 | 0.350 |
Why?
| Milk Proteins | 2 | 1999 | 39 | 0.340 |
Why?
| Drug Resistance, Neoplasm | 6 | 2010 | 673 | 0.340 |
Why?
| Neoplasm Metastasis | 4 | 2020 | 563 | 0.340 |
Why?
| Neoplasm Recurrence, Local | 4 | 2013 | 903 | 0.330 |
Why?
| Neoplasm Transplantation | 4 | 2014 | 248 | 0.330 |
Why?
| Protein Multimerization | 1 | 2009 | 165 | 0.320 |
Why?
| Aromatase Inhibitors | 1 | 2008 | 52 | 0.320 |
Why?
| Nuclear Receptor Coactivator 1 | 4 | 2012 | 10 | 0.320 |
Why?
| Amino Acid Sequence | 12 | 2009 | 2123 | 0.320 |
Why?
| Saccharomyces cerevisiae Proteins | 2 | 2001 | 354 | 0.300 |
Why?
| Cysteine Endopeptidases | 3 | 2012 | 61 | 0.300 |
Why?
| Cyclic AMP | 5 | 2006 | 260 | 0.300 |
Why?
| Cell Fusion | 1 | 2006 | 51 | 0.290 |
Why?
| Ligands | 9 | 2009 | 582 | 0.290 |
Why?
| Breast | 5 | 2001 | 141 | 0.280 |
Why?
| Selective Estrogen Receptor Modulators | 2 | 2010 | 26 | 0.280 |
Why?
| Trans-Activators | 5 | 1999 | 382 | 0.270 |
Why?
| Ovarian Neoplasms | 1 | 2010 | 460 | 0.260 |
Why?
| Models, Theoretical | 2 | 2008 | 574 | 0.260 |
Why?
| Protein Binding | 10 | 2009 | 2010 | 0.260 |
Why?
| Base Sequence | 11 | 2009 | 2186 | 0.250 |
Why?
| DNA, Neoplasm | 6 | 1992 | 155 | 0.250 |
Why?
| Epithelial Cells | 2 | 2010 | 995 | 0.250 |
Why?
| RNA, Messenger | 11 | 2010 | 2720 | 0.240 |
Why?
| Gonanes | 5 | 1997 | 28 | 0.240 |
Why?
| Lymph Nodes | 1 | 2006 | 466 | 0.240 |
Why?
| Drug Resistance | 8 | 2000 | 169 | 0.240 |
Why?
| Cell Growth Processes | 3 | 2010 | 56 | 0.230 |
Why?
| Estrogen Receptor Modulators | 3 | 2008 | 19 | 0.230 |
Why?
| Mutation | 7 | 2012 | 3493 | 0.230 |
Why?
| Sumoylation | 2 | 2013 | 16 | 0.230 |
Why?
| Molecular Weight | 11 | 2000 | 346 | 0.230 |
Why?
| Disease Models, Animal | 4 | 2014 | 3799 | 0.220 |
Why?
| Receptors, Cell Surface | 7 | 1994 | 368 | 0.220 |
Why?
| Receptors, Steroid | 3 | 1999 | 54 | 0.220 |
Why?
| Peptide Fragments | 5 | 2003 | 715 | 0.220 |
Why?
| ErbB Receptors | 4 | 2020 | 571 | 0.220 |
Why?
| Phosphoserine | 2 | 2000 | 34 | 0.210 |
Why?
| Xenograft Model Antitumor Assays | 4 | 2012 | 747 | 0.210 |
Why?
| Norpregnadienes | 3 | 1988 | 7 | 0.210 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1999 | 178 | 0.200 |
Why?
| Antibodies, Monoclonal | 9 | 2006 | 1306 | 0.200 |
Why?
| Leucine Zippers | 3 | 1997 | 16 | 0.200 |
Why?
| Transfection | 8 | 2006 | 909 | 0.200 |
Why?
| Immunohistochemistry | 6 | 2008 | 1727 | 0.200 |
Why?
| Multienzyme Complexes | 2 | 2003 | 65 | 0.200 |
Why?
| Mitogen-Activated Protein Kinases | 2 | 2000 | 306 | 0.190 |
Why?
| Antigens, Nuclear | 1 | 2000 | 19 | 0.190 |
Why?
| Homeodomain Proteins | 3 | 2009 | 484 | 0.180 |
Why?
| Recombinant Fusion Proteins | 6 | 2000 | 661 | 0.180 |
Why?
| Poly(ADP-ribose) Polymerases | 1 | 2000 | 88 | 0.180 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2010 | 1003 | 0.180 |
Why?
| Response Elements | 3 | 2009 | 85 | 0.180 |
Why?
| Estrogen Antagonists | 9 | 2000 | 39 | 0.180 |
Why?
| Prolactin | 2 | 1998 | 97 | 0.170 |
Why?
| Receptor Cross-Talk | 1 | 1998 | 23 | 0.170 |
Why?
| Amino Acid Motifs | 3 | 2006 | 206 | 0.170 |
Why?
| DNA Helicases | 1 | 2000 | 136 | 0.170 |
Why?
| Kinetics | 15 | 2001 | 1658 | 0.170 |
Why?
| Hormone Antagonists | 2 | 1997 | 41 | 0.170 |
Why?
| Carcinogenesis | 1 | 2020 | 184 | 0.170 |
Why?
| Tumor Suppressor Proteins | 2 | 1998 | 299 | 0.170 |
Why?
| Disease Susceptibility | 1 | 2021 | 343 | 0.170 |
Why?
| Protein Structure, Tertiary | 3 | 2012 | 832 | 0.160 |
Why?
| Progesterone Congeners | 5 | 2008 | 15 | 0.160 |
Why?
| Affinity Labels | 9 | 1990 | 26 | 0.160 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 4 | 1999 | 114 | 0.160 |
Why?
| MAP Kinase Signaling System | 1 | 2000 | 304 | 0.160 |
Why?
| Proto-Oncogene Proteins c-fos | 2 | 1998 | 196 | 0.160 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 2 | 2012 | 119 | 0.160 |
Why?
| Oxygenases | 1 | 1997 | 10 | 0.160 |
Why?
| Risk | 1 | 2021 | 890 | 0.160 |
Why?
| CDC2-CDC28 Kinases | 1 | 1997 | 18 | 0.160 |
Why?
| Endometrial Neoplasms | 4 | 2008 | 144 | 0.160 |
Why?
| Mutagenesis, Site-Directed | 5 | 2001 | 368 | 0.160 |
Why?
| Oligonucleotide Array Sequence Analysis | 4 | 2010 | 783 | 0.160 |
Why?
| Nafoxidine | 8 | 1982 | 9 | 0.150 |
Why?
| Endometrium | 2 | 2008 | 61 | 0.150 |
Why?
| Phosphoproteins | 3 | 2008 | 332 | 0.150 |
Why?
| Endopeptidases | 2 | 2012 | 73 | 0.150 |
Why?
| Hyaluronan Receptors | 2 | 2008 | 96 | 0.150 |
Why?
| Ribosomal Proteins | 1 | 1997 | 68 | 0.150 |
Why?
| 8-Bromo Cyclic Adenosine Monophosphate | 2 | 1994 | 17 | 0.150 |
Why?
| Immunoblotting | 4 | 2004 | 318 | 0.150 |
Why?
| Carcinogens | 1 | 1997 | 110 | 0.150 |
Why?
| Carcinoma, Endometrioid | 2 | 2008 | 47 | 0.150 |
Why?
| Cytoplasm | 12 | 2006 | 276 | 0.150 |
Why?
| Cluster Analysis | 4 | 2008 | 493 | 0.140 |
Why?
| Muscle, Smooth, Vascular | 4 | 2000 | 454 | 0.140 |
Why?
| Microtubule-Associated Proteins | 1 | 1997 | 187 | 0.140 |
Why?
| Up-Regulation | 3 | 2009 | 891 | 0.140 |
Why?
| Tumor Microenvironment | 2 | 2020 | 457 | 0.140 |
Why?
| Receptors, Glucocorticoid | 7 | 2000 | 136 | 0.130 |
Why?
| Blotting, Western | 6 | 2010 | 1225 | 0.130 |
Why?
| Consensus Sequence | 2 | 2009 | 70 | 0.130 |
Why?
| Phenotype | 5 | 2011 | 3070 | 0.130 |
Why?
| Apoptosis | 5 | 2011 | 2532 | 0.130 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 1996 | 196 | 0.130 |
Why?
| Mammary Neoplasms, Experimental | 7 | 2009 | 63 | 0.130 |
Why?
| Proto-Oncogene Proteins c-jun | 1 | 1994 | 47 | 0.130 |
Why?
| Methylation | 1 | 2015 | 209 | 0.120 |
Why?
| Fibroblasts | 2 | 2020 | 846 | 0.120 |
Why?
| Human Umbilical Vein Endothelial Cells | 1 | 2014 | 93 | 0.120 |
Why?
| Heterografts | 1 | 2014 | 132 | 0.120 |
Why?
| Drug Screening Assays, Antitumor | 1 | 2014 | 190 | 0.120 |
Why?
| Small Molecule Libraries | 1 | 2014 | 83 | 0.120 |
Why?
| Ubiquitination | 1 | 2013 | 91 | 0.120 |
Why?
| Estrenes | 4 | 1989 | 16 | 0.120 |
Why?
| Immunophenotyping | 1 | 2014 | 288 | 0.120 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2006 | 432 | 0.120 |
Why?
| Cell Cycle Proteins | 1 | 1997 | 576 | 0.120 |
Why?
| Immunoenzyme Techniques | 2 | 2010 | 201 | 0.110 |
Why?
| Drug Synergism | 4 | 1998 | 346 | 0.110 |
Why?
| Acetylation | 1 | 2013 | 227 | 0.110 |
Why?
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2012 | 26 | 0.110 |
Why?
| Pregnancy Complications, Neoplastic | 1 | 2013 | 52 | 0.110 |
Why?
| Bone Neoplasms | 1 | 2014 | 197 | 0.110 |
Why?
| Chickens | 6 | 1994 | 188 | 0.110 |
Why?
| DNA, Complementary | 4 | 2001 | 270 | 0.110 |
Why?
| Carcinoma, Lobular | 1 | 2012 | 56 | 0.110 |
Why?
| Disease Progression | 3 | 2014 | 2546 | 0.110 |
Why?
| Claudins | 1 | 2011 | 24 | 0.100 |
Why?
| Cytosol | 9 | 1989 | 229 | 0.100 |
Why?
| Bridged-Ring Compounds | 1 | 2011 | 11 | 0.100 |
Why?
| Pyrrolidines | 3 | 1981 | 57 | 0.100 |
Why?
| M Phase Cell Cycle Checkpoints | 1 | 2011 | 23 | 0.100 |
Why?
| Amyloid Precursor Protein Secretases | 1 | 2011 | 75 | 0.100 |
Why?
| Nuclear Receptor Co-Repressor 1 | 3 | 2000 | 16 | 0.100 |
Why?
| Estrogen Receptor alpha | 2 | 2010 | 126 | 0.100 |
Why?
| Cells, Cultured | 10 | 2006 | 4162 | 0.100 |
Why?
| Polyploidy | 1 | 1990 | 21 | 0.100 |
Why?
| Taxoids | 1 | 2011 | 98 | 0.100 |
Why?
| Genome, Human | 1 | 2013 | 392 | 0.100 |
Why?
| Receptor, Insulin | 3 | 1985 | 101 | 0.100 |
Why?
| Acetylcysteine | 2 | 2003 | 150 | 0.090 |
Why?
| Liver Neoplasms | 1 | 2014 | 546 | 0.090 |
Why?
| COS Cells | 2 | 2003 | 187 | 0.090 |
Why?
| Hormones | 2 | 1993 | 136 | 0.090 |
Why?
| Cloning, Molecular | 4 | 2006 | 551 | 0.090 |
Why?
| Chemokine CXCL12 | 1 | 2010 | 81 | 0.090 |
Why?
| Organ Specificity | 1 | 2010 | 287 | 0.090 |
Why?
| Histones | 1 | 2015 | 562 | 0.090 |
Why?
| Antineoplastic Agents | 2 | 2008 | 1990 | 0.090 |
Why?
| Epitopes | 1 | 1991 | 450 | 0.090 |
Why?
| Nuclear Receptor Co-Repressor 2 | 2 | 2000 | 14 | 0.090 |
Why?
| Neoadjuvant Therapy | 2 | 2010 | 348 | 0.090 |
Why?
| Neoplasms, Experimental | 3 | 2008 | 162 | 0.090 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 2009 | 159 | 0.090 |
Why?
| Transformation, Genetic | 1 | 1988 | 15 | 0.090 |
Why?
| STAT5 Transcription Factor | 2 | 1999 | 44 | 0.090 |
Why?
| Time Factors | 4 | 2008 | 6682 | 0.080 |
Why?
| Embryonal Carcinoma Stem Cells | 1 | 2008 | 2 | 0.080 |
Why?
| Drug Administration Routes | 1 | 2008 | 44 | 0.080 |
Why?
| Transcriptome | 1 | 2014 | 774 | 0.080 |
Why?
| Mitogen-Activated Protein Kinase 3 | 2 | 2000 | 159 | 0.080 |
Why?
| Receptors, Androgen | 4 | 2005 | 136 | 0.080 |
Why?
| Mitogen-Activated Protein Kinase 1 | 2 | 2000 | 179 | 0.080 |
Why?
| Protein Precursors | 1 | 1989 | 126 | 0.080 |
Why?
| MicroRNAs | 1 | 2015 | 661 | 0.080 |
Why?
| Substrate Specificity | 1 | 2009 | 375 | 0.080 |
Why?
| Microdissection | 1 | 2007 | 15 | 0.080 |
Why?
| Mammary Tumor Virus, Mouse | 2 | 2000 | 41 | 0.080 |
Why?
| Dactinomycin | 4 | 1981 | 26 | 0.080 |
Why?
| Androstadienes | 1 | 2008 | 95 | 0.080 |
Why?
| Binding, Competitive | 6 | 1994 | 205 | 0.080 |
Why?
| Pregnanes | 1 | 1986 | 3 | 0.070 |
Why?
| Lasers | 1 | 2007 | 123 | 0.070 |
Why?
| Structure-Activity Relationship | 2 | 2002 | 536 | 0.070 |
Why?
| Pregnanolone | 1 | 1986 | 21 | 0.070 |
Why?
| Neoplasm Invasiveness | 3 | 2020 | 472 | 0.070 |
Why?
| Receptor, IGF Type 1 | 1 | 2006 | 59 | 0.070 |
Why?
| Transforming Growth Factor beta | 1 | 2009 | 468 | 0.070 |
Why?
| Protein Biosynthesis | 3 | 2000 | 408 | 0.070 |
Why?
| Brain Neoplasms | 1 | 2014 | 1016 | 0.070 |
Why?
| Recombinant Proteins | 3 | 2003 | 1318 | 0.070 |
Why?
| Drug Administration Schedule | 1 | 2008 | 757 | 0.070 |
Why?
| Pleural Effusion | 1 | 2006 | 53 | 0.070 |
Why?
| Mutant Proteins | 1 | 2006 | 101 | 0.070 |
Why?
| Menopause | 2 | 2008 | 270 | 0.070 |
Why?
| Cell Cycle | 2 | 1999 | 584 | 0.070 |
Why?
| Gene Regulatory Networks | 1 | 2007 | 244 | 0.070 |
Why?
| HSP90 Heat-Shock Proteins | 1 | 2006 | 46 | 0.070 |
Why?
| Zinc Fingers | 2 | 1998 | 49 | 0.070 |
Why?
| Dose-Response Relationship, Drug | 5 | 2005 | 1981 | 0.070 |
Why?
| Chromatography, Affinity | 4 | 1990 | 87 | 0.070 |
Why?
| Methionine | 2 | 2000 | 147 | 0.070 |
Why?
| Uterine Neoplasms | 1 | 2006 | 76 | 0.070 |
Why?
| Regulatory Sequences, Nucleic Acid | 3 | 1997 | 84 | 0.070 |
Why?
| Protein Structure, Secondary | 1 | 2006 | 341 | 0.070 |
Why?
| Keratins | 1 | 2005 | 175 | 0.070 |
Why?
| Chromosome Mapping | 4 | 1999 | 518 | 0.070 |
Why?
| Hydroxyprogesterones | 1 | 1985 | 7 | 0.070 |
Why?
| Thromboplastin | 1 | 2004 | 73 | 0.060 |
Why?
| Cycloheximide | 4 | 1989 | 59 | 0.060 |
Why?
| Dexamethasone | 5 | 2000 | 323 | 0.060 |
Why?
| Chloramphenicol O-Acetyltransferase | 2 | 1994 | 36 | 0.060 |
Why?
| Dimerization | 2 | 2002 | 184 | 0.060 |
Why?
| Cell Transformation, Neoplastic | 1 | 2006 | 320 | 0.060 |
Why?
| Protein Conformation | 2 | 2001 | 851 | 0.060 |
Why?
| Patient Care Planning | 1 | 2005 | 143 | 0.060 |
Why?
| Biomarkers | 1 | 2014 | 3662 | 0.060 |
Why?
| Paclitaxel | 1 | 2004 | 202 | 0.060 |
Why?
| Cell Movement | 2 | 2006 | 929 | 0.060 |
Why?
| Microscopy, Confocal | 1 | 2004 | 319 | 0.060 |
Why?
| Plasmids | 2 | 2002 | 358 | 0.060 |
Why?
| Genes, Reporter | 2 | 1994 | 274 | 0.060 |
Why?
| Proteasome Endopeptidase Complex | 2 | 2003 | 140 | 0.060 |
Why?
| Cell Adhesion | 1 | 2004 | 454 | 0.060 |
Why?
| Mutagenesis | 1 | 2003 | 185 | 0.050 |
Why?
| Sequence Alignment | 1 | 2003 | 343 | 0.050 |
Why?
| Sequence Homology, Amino Acid | 1 | 2003 | 376 | 0.050 |
Why?
| Oligodeoxyribonucleotides | 2 | 1993 | 140 | 0.050 |
Why?
| Flow Cytometry | 3 | 1992 | 1128 | 0.050 |
Why?
| Analysis of Variance | 1 | 2005 | 1329 | 0.050 |
Why?
| Biomedical Research | 1 | 2008 | 630 | 0.050 |
Why?
| Testosterone | 1 | 2005 | 353 | 0.050 |
Why?
| Uterus | 1 | 2003 | 197 | 0.050 |
Why?
| Iron Chelating Agents | 1 | 2001 | 16 | 0.050 |
Why?
| Lung Neoplasms | 1 | 2014 | 2216 | 0.050 |
Why?
| Oligonucleotide Probes | 2 | 1992 | 54 | 0.050 |
Why?
| Growth Substances | 2 | 1999 | 140 | 0.050 |
Why?
| Oviducts | 3 | 1986 | 15 | 0.050 |
Why?
| Cell Differentiation | 2 | 2006 | 1805 | 0.050 |
Why?
| Ultracentrifugation | 1 | 2001 | 49 | 0.050 |
Why?
| Gene Library | 2 | 1992 | 128 | 0.050 |
Why?
| Sequence Deletion | 1 | 2001 | 175 | 0.050 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2004 | 537 | 0.050 |
Why?
| Androgens | 6 | 1986 | 169 | 0.050 |
Why?
| Pregnancy | 1 | 2013 | 5854 | 0.050 |
Why?
| Exons | 2 | 1999 | 310 | 0.050 |
Why?
| Genetic Variation | 2 | 1999 | 952 | 0.050 |
Why?
| CCAAT-Enhancer-Binding Proteins | 1 | 2000 | 34 | 0.050 |
Why?
| DNA-Activated Protein Kinase | 1 | 2000 | 11 | 0.050 |
Why?
| Ku Autoantigen | 1 | 2000 | 12 | 0.050 |
Why?
| CD146 Antigen | 1 | 2020 | 42 | 0.050 |
Why?
| Ubiquitins | 1 | 2000 | 34 | 0.050 |
Why?
| Glutathione Transferase | 1 | 2000 | 98 | 0.050 |
Why?
| Phosphates | 2 | 1993 | 170 | 0.040 |
Why?
| Peptides, Cyclic | 1 | 2001 | 260 | 0.040 |
Why?
| Chromosomes, Human, Pair 17 | 1 | 1999 | 64 | 0.040 |
Why?
| Nucleic Acid Hybridization | 2 | 1990 | 193 | 0.040 |
Why?
| Phosphotyrosine | 1 | 1998 | 47 | 0.040 |
Why?
| Receptors, Growth Factor | 1 | 1998 | 51 | 0.040 |
Why?
| Middle Aged | 5 | 2013 | 28563 | 0.040 |
Why?
| Chromosomes, Human, Pair 6 | 1 | 1998 | 49 | 0.040 |
Why?
| Imidazoles | 1 | 2000 | 234 | 0.040 |
Why?
| STAT1 Transcription Factor | 1 | 1998 | 68 | 0.040 |
Why?
| Immunoassay | 2 | 1989 | 101 | 0.040 |
Why?
| Protein Folding | 1 | 2000 | 255 | 0.040 |
Why?
| Sp1 Transcription Factor | 1 | 1998 | 23 | 0.040 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 1998 | 156 | 0.040 |
Why?
| Suppression, Genetic | 1 | 1998 | 25 | 0.040 |
Why?
| Glycoproteins | 1 | 2000 | 323 | 0.040 |
Why?
| Cyclin B | 1 | 1997 | 14 | 0.040 |
Why?
| Cyclin A | 1 | 1997 | 15 | 0.040 |
Why?
| Dihydrotestosterone | 3 | 1979 | 39 | 0.040 |
Why?
| Isomerism | 1 | 1997 | 43 | 0.040 |
Why?
| Hydrocortisone | 3 | 1985 | 315 | 0.040 |
Why?
| Cell Compartmentation | 3 | 1989 | 58 | 0.040 |
Why?
| Cyclin-Dependent Kinase 2 | 1 | 1997 | 36 | 0.040 |
Why?
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 1997 | 71 | 0.040 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 1998 | 290 | 0.040 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 1997 | 60 | 0.040 |
Why?
| Biological Transport | 1 | 1998 | 392 | 0.040 |
Why?
| Zinc Finger E-box-Binding Homeobox 1 | 2 | 2008 | 25 | 0.040 |
Why?
| G1 Phase | 1 | 1997 | 71 | 0.040 |
Why?
| Blood Platelets | 2 | 1994 | 369 | 0.040 |
Why?
| Yeasts | 1 | 1997 | 52 | 0.040 |
Why?
| Autoantigens | 1 | 2000 | 407 | 0.040 |
Why?
| STAT3 Transcription Factor | 1 | 1998 | 193 | 0.040 |
Why?
| Cyclin-Dependent Kinases | 1 | 1997 | 114 | 0.040 |
Why?
| Chromatin | 1 | 2000 | 450 | 0.040 |
Why?
| Gas Chromatography-Mass Spectrometry | 2 | 1986 | 139 | 0.040 |
Why?
| Adult | 5 | 2013 | 32385 | 0.040 |
Why?
| Pyridines | 1 | 2000 | 440 | 0.040 |
Why?
| Photochemistry | 2 | 1990 | 137 | 0.040 |
Why?
| Centrifugation, Density Gradient | 4 | 1983 | 42 | 0.030 |
Why?
| Gene Expression | 3 | 2006 | 1506 | 0.030 |
Why?
| Precipitin Tests | 2 | 2000 | 99 | 0.030 |
Why?
| Membrane Proteins | 1 | 2001 | 1093 | 0.030 |
Why?
| TATA Box | 1 | 1994 | 25 | 0.030 |
Why?
| Biopolymers | 1 | 1994 | 28 | 0.030 |
Why?
| Molecular Structure | 1 | 1996 | 463 | 0.030 |
Why?
| Prognosis | 3 | 2009 | 3563 | 0.030 |
Why?
| Risk Factors | 1 | 2008 | 9381 | 0.030 |
Why?
| Rats | 6 | 1991 | 5426 | 0.030 |
Why?
| Protein Kinases | 2 | 2008 | 325 | 0.030 |
Why?
| Adenosine Diphosphate | 1 | 1994 | 89 | 0.030 |
Why?
| Chromatography, DEAE-Cellulose | 2 | 1985 | 16 | 0.030 |
Why?
| Genes, jun | 1 | 1993 | 9 | 0.030 |
Why?
| Genes, fos | 1 | 1993 | 36 | 0.030 |
Why?
| Aneuploidy | 1 | 1994 | 87 | 0.030 |
Why?
| beta-Galactosidase | 1 | 1993 | 67 | 0.030 |
Why?
| Antibodies | 2 | 1986 | 400 | 0.030 |
Why?
| In Vitro Techniques | 1 | 1995 | 1130 | 0.030 |
Why?
| Macromolecular Substances | 2 | 1983 | 207 | 0.030 |
Why?
| Karyotyping | 1 | 2012 | 102 | 0.030 |
Why?
| Serotonin | 1 | 1994 | 311 | 0.030 |
Why?
| Castration | 4 | 1982 | 14 | 0.030 |
Why?
| Ploidies | 1 | 1992 | 18 | 0.030 |
Why?
| Reference Values | 1 | 1994 | 789 | 0.030 |
Why?
| 9,10-Dimethyl-1,2-benzanthracene | 2 | 1985 | 22 | 0.030 |
Why?
| Clone Cells | 1 | 1992 | 255 | 0.030 |
Why?
| Ultraviolet Rays | 2 | 1985 | 413 | 0.030 |
Why?
| Cytokines | 1 | 1999 | 1928 | 0.020 |
Why?
| DNA Probes | 1 | 1990 | 62 | 0.020 |
Why?
| Cell Cycle Checkpoints | 1 | 2011 | 89 | 0.020 |
Why?
| Codon | 1 | 1990 | 90 | 0.020 |
Why?
| Peptide Chain Initiation, Translational | 1 | 1990 | 38 | 0.020 |
Why?
| Neoplasms | 1 | 2004 | 2235 | 0.020 |
Why?
| Rabbits | 1 | 1991 | 808 | 0.020 |
Why?
| Glucocorticoids | 5 | 2000 | 554 | 0.020 |
Why?
| Radioligand Assay | 1 | 1989 | 45 | 0.020 |
Why?
| Mitosis | 1 | 2011 | 175 | 0.020 |
Why?
| Acceleration | 1 | 1969 | 31 | 0.020 |
Why?
| Smad3 Protein | 1 | 2009 | 49 | 0.020 |
Why?
| Estrogen Receptor beta | 2 | 2000 | 36 | 0.020 |
Why?
| Cyanogen Bromide | 1 | 1989 | 1 | 0.020 |
Why?
| Formaldehyde | 1 | 1989 | 50 | 0.020 |
Why?
| Estradiol Congeners | 2 | 1981 | 2 | 0.020 |
Why?
| Trypsin | 1 | 1989 | 72 | 0.020 |
Why?
| Peptide Mapping | 1 | 1989 | 65 | 0.020 |
Why?
| Antigen-Antibody Complex | 2 | 1987 | 92 | 0.020 |
Why?
| Mice, SCID | 1 | 2009 | 339 | 0.020 |
Why?
| Microtubules | 1 | 2011 | 247 | 0.020 |
Why?
| Mesoderm | 1 | 2009 | 148 | 0.020 |
Why?
| Endometrial Hyperplasia | 1 | 2008 | 16 | 0.020 |
Why?
| Fluorescent Antibody Technique | 1 | 1989 | 420 | 0.020 |
Why?
| Tissue Array Analysis | 1 | 2008 | 58 | 0.020 |
Why?
| Perilipin-1 | 1 | 2008 | 16 | 0.020 |
Why?
| S100 Proteins | 1 | 2008 | 35 | 0.020 |
Why?
| Phosphorus Radioisotopes | 1 | 1987 | 29 | 0.020 |
Why?
| Mice, Inbred NOD | 1 | 2009 | 588 | 0.020 |
Why?
| Gene Silencing | 1 | 2008 | 178 | 0.020 |
Why?
| Hysterectomy | 1 | 2008 | 119 | 0.020 |
Why?
| Chromatography, High Pressure Liquid | 1 | 1989 | 493 | 0.020 |
Why?
| DNA Primers | 2 | 1998 | 540 | 0.020 |
Why?
| 3-Hydroxysteroid Dehydrogenases | 1 | 1986 | 9 | 0.020 |
Why?
| Protein C Inhibitor | 1 | 2006 | 1 | 0.020 |
Why?
| Steroid Hydroxylases | 1 | 1986 | 22 | 0.020 |
Why?
| Chromatography, Thin Layer | 1 | 1986 | 23 | 0.020 |
Why?
| Chromatography, Gas | 1 | 1986 | 32 | 0.020 |
Why?
| Cadherins | 1 | 2008 | 190 | 0.020 |
Why?
| Ligases | 1 | 2006 | 33 | 0.020 |
Why?
| Insulin Receptor Substrate Proteins | 1 | 2006 | 59 | 0.020 |
Why?
| RNA | 2 | 2005 | 854 | 0.020 |
Why?
| Half-Life | 1 | 1986 | 147 | 0.020 |
Why?
| Tacrolimus Binding Proteins | 1 | 2006 | 16 | 0.020 |
Why?
| Heterotrimeric GTP-Binding Proteins | 1 | 2006 | 18 | 0.020 |
Why?
| Stress, Physiological | 1 | 1969 | 433 | 0.020 |
Why?
| Androstenes | 1 | 2005 | 11 | 0.020 |
Why?
| Adaptor Proteins, Vesicular Transport | 1 | 2006 | 49 | 0.020 |
Why?
| Levonorgestrel | 1 | 2005 | 31 | 0.020 |
Why?
| Desogestrel | 1 | 2005 | 42 | 0.020 |
Why?
| Polymerase Chain Reaction | 2 | 1998 | 1021 | 0.020 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 1986 | 336 | 0.020 |
Why?
| 17-alpha-Hydroxyprogesterone | 1 | 1985 | 3 | 0.020 |
Why?
| Cell Fractionation | 2 | 1982 | 58 | 0.020 |
Why?
| Cricetinae | 2 | 1999 | 269 | 0.020 |
Why?
| Polymers | 1 | 1989 | 475 | 0.020 |
Why?
| Amino Acids | 1 | 1988 | 463 | 0.020 |
Why?
| Aged | 3 | 2012 | 20495 | 0.020 |
Why?
| Alkaline Phosphatase | 1 | 2005 | 161 | 0.020 |
Why?
| Molecular Chaperones | 1 | 2006 | 177 | 0.020 |
Why?
| Calcitriol | 1 | 1985 | 55 | 0.020 |
Why?
| RNA Interference | 1 | 2006 | 473 | 0.020 |
Why?
| Polyethylene Glycols | 1 | 1989 | 560 | 0.020 |
Why?
| Neoplasm Staging | 1 | 2008 | 1234 | 0.020 |
Why?
| Insulin-Like Growth Factor I | 1 | 2006 | 288 | 0.020 |
Why?
| Sucrose | 1 | 2004 | 105 | 0.020 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 1986 | 513 | 0.020 |
Why?
| Genes, Dominant | 1 | 2004 | 97 | 0.020 |
Why?
| Homeostasis | 1 | 1988 | 596 | 0.020 |
Why?
| Receptors, Adrenergic, beta | 1 | 1985 | 146 | 0.020 |
Why?
| NIH 3T3 Cells | 1 | 2004 | 141 | 0.020 |
Why?
| Carrier Proteins | 1 | 2008 | 740 | 0.010 |
Why?
| Chromatography, Gel | 1 | 1983 | 129 | 0.010 |
Why?
| Butadienes | 1 | 2003 | 34 | 0.010 |
Why?
| Cysteine Proteinase Inhibitors | 1 | 2003 | 51 | 0.010 |
Why?
| Lymphocytes | 1 | 1985 | 360 | 0.010 |
Why?
| Active Transport, Cell Nucleus | 1 | 2003 | 115 | 0.010 |
Why?
| Fatty Acids, Unsaturated | 1 | 2003 | 87 | 0.010 |
Why?
| Disease-Free Survival | 1 | 2004 | 661 | 0.010 |
Why?
| Serine | 1 | 2003 | 142 | 0.010 |
Why?
| Nitriles | 1 | 2003 | 158 | 0.010 |
Why?
| Bromodeoxyuridine | 1 | 1982 | 78 | 0.010 |
Why?
| Hypophysectomy | 3 | 1977 | 15 | 0.010 |
Why?
| RNA, Small Interfering | 1 | 2004 | 581 | 0.010 |
Why?
| Lipid Metabolism | 1 | 1985 | 482 | 0.010 |
Why?
| Butyrates | 1 | 1982 | 55 | 0.010 |
Why?
| Cell Survival | 1 | 2004 | 1075 | 0.010 |
Why?
| Deoxyadenosines | 1 | 1980 | 6 | 0.010 |
Why?
| Dogs | 1 | 1982 | 382 | 0.010 |
Why?
| NFI Transcription Factors | 1 | 2000 | 4 | 0.010 |
Why?
| Y-Box-Binding Protein 1 | 1 | 2000 | 4 | 0.010 |
Why?
| Proportional Hazards Models | 1 | 2004 | 1184 | 0.010 |
Why?
| Diethylstilbestrol | 2 | 1979 | 9 | 0.010 |
Why?
| Clinical Trials as Topic | 1 | 1984 | 985 | 0.010 |
Why?
| Aorta | 1 | 1982 | 368 | 0.010 |
Why?
| Culture Techniques | 1 | 1999 | 81 | 0.010 |
Why?
| Testosterone Congeners | 1 | 1979 | 8 | 0.010 |
Why?
| Coumestrol | 1 | 1978 | 1 | 0.010 |
Why?
| Mycotoxins | 1 | 1978 | 3 | 0.010 |
Why?
| Coumarins | 1 | 1978 | 21 | 0.010 |
Why?
| Isoflavones | 1 | 1978 | 24 | 0.010 |
Why?
| Premenopause | 1 | 1999 | 109 | 0.010 |
Why?
| Insulin | 1 | 1988 | 2180 | 0.010 |
Why?
| Flavonoids | 1 | 1978 | 73 | 0.010 |
Why?
| Subcellular Fractions | 1 | 1978 | 86 | 0.010 |
Why?
| Remission, Spontaneous | 1 | 1977 | 37 | 0.010 |
Why?
| Gene Deletion | 1 | 1999 | 365 | 0.010 |
Why?
| In Situ Hybridization, Fluorescence | 1 | 1998 | 319 | 0.010 |
Why?
| Regression Analysis | 1 | 2000 | 1018 | 0.010 |
Why?
| Postmenopause | 1 | 1999 | 307 | 0.010 |
Why?
| Adrenal Glands | 1 | 1977 | 75 | 0.010 |
Why?
| Hypersensitivity | 1 | 2000 | 259 | 0.010 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1984 | 1402 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2008 | 6845 | 0.010 |
Why?
| Sex Factors | 1 | 1982 | 1860 | 0.010 |
Why?
| Mice, Inbred C57BL | 1 | 2006 | 5020 | 0.010 |
Why?
| Fluoxymesterone | 1 | 1975 | 2 | 0.010 |
Why?
| Ovary | 1 | 1977 | 209 | 0.010 |
Why?
| Recurrence | 1 | 1977 | 998 | 0.010 |
Why?
| Nucleic Acid Conformation | 1 | 1997 | 674 | 0.010 |
Why?
| Cattle | 1 | 1994 | 994 | 0.010 |
Why?
| Clostridium tetani | 1 | 1969 | 1 | 0.010 |
Why?
| Nystagmus, Pathologic | 1 | 1969 | 7 | 0.010 |
Why?
| Treatment Outcome | 1 | 2004 | 9692 | 0.010 |
Why?
| Genetic Vectors | 1 | 1990 | 310 | 0.010 |
Why?
| Peptides | 1 | 1994 | 893 | 0.010 |
Why?
| Corticosterone | 1 | 1969 | 254 | 0.010 |
Why?
| Salmonella typhimurium | 1 | 1969 | 179 | 0.000 |
Why?
| Male | 3 | 1999 | 59639 | 0.000 |
Why?
| Hybridomas | 1 | 1987 | 236 | 0.000 |
Why?
| Adrenalectomy | 2 | 1977 | 79 | 0.000 |
Why?
| Pindolol | 1 | 1985 | 16 | 0.000 |
Why?
| Mice, Inbred BALB C | 1 | 1987 | 1245 | 0.000 |
Why?
| Blood Proteins | 1 | 1985 | 249 | 0.000 |
Why?
| Solubility | 1 | 1980 | 240 | 0.000 |
Why?
| Zeranol | 1 | 1978 | 1 | 0.000 |
Why?
| Zearalenone | 1 | 1978 | 2 | 0.000 |
Why?
| Sex Hormone-Binding Globulin | 1 | 1978 | 49 | 0.000 |
Why?
| Aminoglutethimide | 1 | 1977 | 8 | 0.000 |
Why?
| Species Specificity | 1 | 1976 | 578 | 0.000 |
Why?
|
|
Horwitz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|